Union Korea Pharm Balance Sheet Health
Financial Health criteria checks 3/6
Union Korea Pharm has a total shareholder equity of ₩27.3B and total debt of ₩36.9B, which brings its debt-to-equity ratio to 135.1%. Its total assets and total liabilities are ₩90.2B and ₩62.8B respectively.
Key information
135.1%
Debt to equity ratio
₩36.91b
Debt
Interest coverage ratio | n/a |
Cash | ₩4.88b |
Equity | ₩27.32b |
Total liabilities | ₩62.84b |
Total assets | ₩90.16b |
Recent financial health updates
Is Union Korea Pharm (KOSDAQ:080720) A Risky Investment?
Apr 23Union Korea Pharm (KOSDAQ:080720) Is Carrying A Fair Bit Of Debt
Jan 27Recent updates
Is Union Korea Pharm (KOSDAQ:080720) A Risky Investment?
Apr 23Union Korea Pharm (KOSDAQ:080720) Is Carrying A Fair Bit Of Debt
Jan 27What Percentage Of Union Korea Pharm Co., Ltd. (KOSDAQ:080720) Shares Do Insiders Own?
Dec 22The Union Korea Pharm (KOSDAQ:080720) Share Price Has Gained 38% And Shareholders Are Hoping For More
Nov 17Financial Position Analysis
Short Term Liabilities: A080720's short term assets (₩45.9B) do not cover its short term liabilities (₩57.5B).
Long Term Liabilities: A080720's short term assets (₩45.9B) exceed its long term liabilities (₩5.3B).
Debt to Equity History and Analysis
Debt Level: A080720's net debt to equity ratio (117.2%) is considered high.
Reducing Debt: A080720's debt to equity ratio has increased from 25.7% to 135.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable A080720 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: A080720 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 24.9% per year.